Author Archives: Patricia Inacio, PhD

Mitochondrial DNA Damage Linked to Vascular Alterations in Diabetics

Increased mitochondrial DNA damage in peripheral blood mononuclear cells of patients with diabetes mellitus and clinical atherosclerotic cardiovascular disease is associated with microvascular alterations, specifically, microvascular pulsability. The study, “Mitochondrial DNA damage and vascular function in patients with diabetes mellitus and atherosclerotic cardiovascular disease,” was published in the journal Cardiovascular Diabetology.

Mitochondria Dysfunction Seen to Affect Interneuron Development in Brains of Mice, Possibly Leading to Neurological Disorders

Mitochondria dysfunction disrupts normal development of interneurons, which may underlie the neurological symptoms of autism spectrum disorder, according to the results of a recent study, “Differential Mitochondrial Requirements for Radially and Non-radially Migrating Cortical Neurons: Implications for Mitochondrial Disorders,” published in the journal Cell Reports. Mitochondria are key organelles…

Gene Therapy May Rescue Visual Acuity in People with LHON Disease

In a study in the journal Scientific Reports, researchers propose that gene therapy may be a safe and efficient strategy to treat Leber’s hereditary optic neuropathy disease (LHON). The study is titled “Efficacy and Safety of rAAV2-ND4 Treatment for Leber’s Hereditary Optic Neuropathy.” LHON is a neurodegenerative mitochondria disease that leads to blindness.

Mitochondria Successfully Treated with Novel Oxidative Stress ‘Scavengers’ in Alzheimer’s Mouse Model

Targeting mitochondria with ceria nanoparticles effectively suppressed the death of neuron cells in a mouse model for Alzheimer’s disease, according to the recent study, “Mitochondria-Targeting Ceria Nanoparticles as Antioxidants for Alzheimer’s Disease,” published in the ACS Nano journal. Mitochondrial oxidative stress is known to promote the pathological progression…

Mitochondrial Genome Alterations Seen as a Risk Factor for Pediatric Acute Myeloid Leukemia

Alterations in mitochondrial DNA (mtDNA) are associated with the risk for pediatric acute myeloid leukemia (AML), according to a study titled “Clinicopathological Implications of Mitochondrial Genome Alterations in Pediatric Acute Myeloid Leukemia” and published in the journal Annals of Laboratory Medicine. Mitochondria are key organelles within cells that are…

Mitochondrial DNA Variations May Spur Symptoms in People with Form of Chronic Fatigue

Specific variations in the mitochondria DNA genome correlate with an increased likelihood of symptoms in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), according to a study titled “Mitochondrial DNA variants correlate with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome,” published in the Journal of Translational Medicine. ME/CFS is a rare acquired…